发明名称 |
PSP94: USE FOR TREATMENT OF HYPERCALCEMIA AND BONE METASTASIS |
摘要 |
The present invention discloses the use of PSP-94 for treating a patient suffering from hypercalcemia of malignancy. Prostate secretory protein of 94 amino acids (P SP- 94) is known to serve as prognostic marker in hormone-dependent prostate. In the current study the effect of PSP-94 on prostate cancer growth, metastases to the skeleton and hypercalcemia of malignancy was examined. A marked dose-dependent decrease in primary tumor volume was seen in experimental animals receiving PSP-94. Furthermore, while control animals routinely developed hypercalcemia due to PTHrP production, treatment with PSP-94 led t o a near normalization of plasma calcium and a marked reduction in PTHrP production a s determined by radioimmunoassay and immunohistochemistry. Results obtained demonstrate t he ability of PSP-94 to be an effective treatment modality for prostate cancer. Furthermor e, decrease in plasma PTHrP and calcium levels can serve as useful biochemical markers for monitoring the efficacy of this novel anti-tumor agent.
|
申请公布号 |
CA2407548(A1) |
申请公布日期 |
2003.05.08 |
申请号 |
CA20022407548 |
申请日期 |
2002.11.08 |
申请人 |
PROCYON BIOPHARMA INC. |
发明人 |
RABBANI, SHAFAAT AHMED;SHUKEIR, NICHOLAS;NEWMAN, CHRISTOPHER;PANCHAL, CHANDRA J. |
分类号 |
A61K38/17;G01N33/574;G01N33/84;(IPC1-7):A61K38/17;A61P19/00 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|